GlassScriptPhysician profile
Jason Willard Balls
NPI 1710264528
$2,865.72
in general payments reported to CMS, 2019-2025
21 companies · $220 in 2025
The $220 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $564 · 2022: $899 · 2023: $735 · 2024: $448 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,403.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $789.24 | 2021-2025 | Jakafi, Niktimvo |
| Takeda Pharmaceuticals U.S.A., INC. | $457.23 | 2022-2024 | Livtencity, Iclusig |
| Kite Pharma, INC. | $246.77 | 2022 | |
| Astellas Pharma US INC | $226.30 | 2021-2022 | |
| Celgene Corporation | $181.73 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $152.89 | 2021-2022 | |
| Pfizer INC. | $126.40 | 2023-2024 | |
| Melinta Therapeutics, LLC | $125.00 | 2024 | Rezzayo |
| Syndax Pharmaceuticals, INC. | $90.10 | 2025 | |
| Novartis Pharmaceuticals Corporation | $87.17 | 2022-2023 | |
| Legend Biotech USA INC. | $72.56 | 2023-2024 | Carvykti |
| Shionogi INC | $55.36 | 2023-2024 | Fetroja |
| Genmab U.S., INC. | $46.37 | 2023 | Epkinly |
| Sanofi-Aventis U.S. LLC | $37.21 | 2022 | |
| Beigene USA, INC. | $35.42 | 2023 | Brukinsa |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $29.08 | 2024 | |
| La Jolla Pharmaceutical Company | $27.17 | 2024 | Xacduro |
| Stemline Therapeutics INC. | $22.97 | 2024 | Elzonris |
| Adaptive Biotechnologies Corporation | $22.93 | 2023 | Clonoseq |
| Genzyme Corporation | $19.88 | 2024 | |
| Seagen INC. | $13.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Balls listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.